B-Type Natriuretic Peptide - A Biomarker for All Seasons?

New England Journal of Medicine

Volumn 350, Issue 7, 2004, Pages 718-720

  Mark, Daniel B ^a   Felker, G Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ANAMNESIS; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EDITORIAL; HEALTH CARE COST; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; BLOOD; CONGESTIVE HEART FAILURE; DYSPNEA; FEMALE; HUMAN; MALE; MORTALITY; NOTE; PROGNOSIS; RISK;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MORTALITY; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK;

EID: 1442265576     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe038233     Document Type: Editorial

References (10)

1. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
2. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-8.
3. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54.
4. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63.
5. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60. [Erratum, Eur Heart J 2001;22:2217-8.]
6. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60. [Erratum, Eur Heart J 2001;22:2217-8.]
7. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
8. Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004;43:55-60.
9. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
10. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-22.